Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.1868G>T | p.Cys623Phe | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
TGC | Cys | TTC | Phe | G->T | Tv |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
cb EGF-like #06 | Disulfide bonds 623-637 (C2) | No | No |
At the mRNA level | On restriction map |
NA | New restriction site(s): BspH I Lost restriction site(s): none |
Conservation (0-1) | SIFT (0-1) | UMD-predictor (0-100) |
---|---|---|
0.83 | 0.00 (pathogenous) | 100 (Pathogenous) |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
USA09FAR F0004 I01 | Proband | Male | de novo | U.S.A. |
Phenotypic group | Disease |
NA | MFS |
Symptom | Severity | Age |
33 | ||
C-Asc. aortic dilatation | 33 | |
CNS-Lumbosacral dural ectasia | 33 | |
O-Ectopia lentis | bilateral | 33 |
S-High arched palate | 33 | |
S-Pectus excavatum moderate (m)(1) | 33 | |
S-Reduced US/LS ratio <0.87 (M) | 33 | |
SI-Significant striae atrophicae (m)(1) | shoulder | 33 |
SI-Significant striae atrophicae (m)(1) | flank | 33 |
SI-Significant striae atrophicae (m)(1) | hip | 33 |
Reference ID | PubMed ID | Reference |
210 | 11251996 | Toudjarska I, Kilpatrick MW, Lembessis P, Carra S, Harton GL, Sisson ME, Black SH, Stern HJ, Gelman-Kohan Z, Shohat M, Tsipouras P. "Novel approach to the molecular diagnosis of Marfan syndrome: application to sporadic cases and in prenatal diagnosis". Am J Med Genet. 2001 Apr 1;99(4):294-302. |